98 related articles for article (PubMed ID: 25520093)
1. Clinical significance of serum vascular endothelial growth factor and complement 3a levels in patients with colorectal cancer in southern Iran.
Mehrabani D; Shamsdin SA; Dehghan A; Safarpour A
Asian Pac J Cancer Prev; 2014; 15(22):9713-7. PubMed ID: 25520093
[TBL] [Abstract][Full Text] [Related]
2. Serum vascular endothelial growth factor-C and vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance.
Xu T; Chen D
J Huazhong Univ Sci Technolog Med Sci; 2006; 26(3):329-31, 355. PubMed ID: 16961284
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of VEGF levels in serums of colorectal cancer patients at stage IV].
Huang N; Yang L; Cao MR; Su N; Chen JZ; Lü CW; Liao WJ; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):278-9. PubMed ID: 19246299
[TBL] [Abstract][Full Text] [Related]
4. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
[TBL] [Abstract][Full Text] [Related]
5. Correlations of serum VEGF and MMP-2 levels with CLM in CRC patients and effects of TACE on their expressions.
Xu H; Ren YJ; Liu K; Min XL; Yang L; Zhou Y; Zheng J; Yang C
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3394-3401. PubMed ID: 29917190
[TBL] [Abstract][Full Text] [Related]
6. Increased serum levels of complement C3a anaphylatoxin indicate the presence of colorectal tumors.
Habermann JK; Roblick UJ; Luke BT; Prieto DA; Finlay WJ; Podust VN; Roman JM; Oevermann E; Schiedeck T; Homann N; Duchrow M; Conrads TP; Veenstra TD; Burt SK; Bruch HP; Auer G; Ried T
Gastroenterology; 2006 Oct; 131(4):1020-9; quiz 1284. PubMed ID: 17030172
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17 may be a valuable serum tumor marker in patients with colorectal carcinoma.
Radosavljevic G; Ljujic B; Jovanovic I; Srzentic Z; Pavlovic S; Zdravkovic N; Milovanovic M; Bankovic D; Knezevic M; Acimovic LJ; Arsenijevic N
Neoplasma; 2010; 57(2):135-44. PubMed ID: 20099977
[TBL] [Abstract][Full Text] [Related]
8. Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
Kocael A; Vatankulu B; Şimşek O; Cengiz M; Kemik A; Kocael P; Halaç M; Sönmezoğlu K; Ulualp K
Tumour Biol; 2016 Mar; 37(3):3871-7. PubMed ID: 26476536
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of serum Tie-2 and vascular endothelial growth factor levels in cancer patients.
Seker MM; Sancaktar E; Acibucu DO; Filiz AK; Deveci K; Bahceci A; Kacan T; Babacan N; Yuce S
Eur Rev Med Pharmacol Sci; 2013 Nov; 17(21):2929-32. PubMed ID: 24254563
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of serum angiogenic activity in colorectal cancer patients.
Gonzalez FJ; Quesada AR; Sevilla I; Baca JJ; Medina MA; Amores J; Diaz JM; Rius-Diaz F; Marques E; Alba E
J Cell Mol Med; 2007; 11(1):120-8. PubMed ID: 17367506
[TBL] [Abstract][Full Text] [Related]
11. The Prognostic Value of Serum Semaphorin3A and VEGF Levels in Patients with Metastatic Colorectal Cancer.
Karpuz T; Araz M; Korkmaz L; Kılınc I; Findik S; Karaagaç M; Eryilmaz MK; Artac M
J Gastrointest Cancer; 2020 Jun; 51(2):491-497. PubMed ID: 31218581
[TBL] [Abstract][Full Text] [Related]
12. Plasma vascular endothelial growth factors A and C in patients undergoing prostatic biopsy and TURP for suspected prostatic neoplasia.
Singh A; Gautam KA; Dalela D; Sankhwar S; Natu S; Sankhwar P; Srivastava A
Asian Pac J Cancer Prev; 2013; 14(3):2053-8. PubMed ID: 23679318
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia related growth factors and p53 in preoperative sera from patients with colorectal cancer--evaluation of the prognostic significance of these agents.
Sulkowski S; Wincewicz A; Zalewski B; Famulski W; Lotowska JM; Koda M; Sobaniec-Lotowska ME; Mysliwiec M; Baltaziak M; Pawlak K; Sulkowska M
Clin Chem Lab Med; 2009; 47(11):1439-45. PubMed ID: 19817649
[TBL] [Abstract][Full Text] [Related]
14. Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancer.
Gil-Bazo I; Catalán Goni V; Alonso Gutiérrez A; Rodríguez Rodríguez J; Páramo Fernández JA; de la Cámara Gómez J; Hernández Lizoain JL; García-Foncillas López J
Clin Transl Oncol; 2005 May; 7(4):150-5. PubMed ID: 15960922
[TBL] [Abstract][Full Text] [Related]
15. Pathologic response during chemo-radiotherapy and variation of serum VEGF levels could predict effects of chemo-radiotherapy in patients with esophageal cancer.
Yu JP; Lu WB; Wang JL; Ni XC; Wang J; Sun ZQ; Sun SP
Asian Pac J Cancer Prev; 2015; 16(3):1111-6. PubMed ID: 25735340
[TBL] [Abstract][Full Text] [Related]
16. Serum cytokine levels in patients with colorectal cancers according to tumor stages and VEGF gene polymorphism.
Bayhan Z; Simşek T; Ergül E; Utkan NZ; Canturk NZ; Cekmen M
Hepatogastroenterology; 2014 Oct; 61(135):1889-94. PubMed ID: 25713884
[TBL] [Abstract][Full Text] [Related]
17. High serum levels of vascular endothelial growth factor-A and transforming growth factor-β1 before neoadjuvant chemoradiotherapy predict poor outcomes in patients with esophageal squamous cell carcinoma receiving combined modality therapy.
Cheng JC; Graber MS; Hsu FM; Tsai CL; Castaneda L; Lee JM; Chang DT; Koong AC
Ann Surg Oncol; 2014 Jul; 21(7):2361-8. PubMed ID: 24623035
[TBL] [Abstract][Full Text] [Related]
18. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients.
Roumen RM; Slooter GD; Croiset van Uchelen FA; Huib LV
Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896
[TBL] [Abstract][Full Text] [Related]
19. Influence of serum VEGF levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancer.
Du K; Gong HY; Gong ZM
Asian Pac J Cancer Prev; 2014; 15(20):8793-6. PubMed ID: 25374209
[TBL] [Abstract][Full Text] [Related]
20. P53 correlates positively with VEGF in preoperative sera of colorectal cancer patients.
Famulski W; Sulkowska M; Wincewicz A; Kedra B; Pawlak K; Zalewski B; Sulkowski S; Koda M; Baltaziak M
Neoplasma; 2006; 53(1):43-8. PubMed ID: 16416012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
